SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION
Karolinska Institutet
500 participants
Jan 1, 2024
OBSERVATIONAL
Conditions
Summary
The aim of the SAID study is to create a national resource in Sweden to enable comprehensive immunological analyses of an extremely complex and clinically challenging group of individuals with variable forms of immune system dysregulation. We hope to establish a biobank of primarily blood and fecal samples from children and adults, with confirmed or suspected immune dysregulation, as well as age- and sex- matched healthy controls, for comparisons of immune cell/mediator alongside various clinical presentations of these immunological diseases as well as microbiome samples as possible a possible modifier of clinical presentations. The project will also include the establishment of a national database with deep immunological data, treatment and clinical outcomes for these patients, accessible to participating researchers and clinicians.
Eligibility
Inclusion Criteria1
- Patients of all ages seeking care or being referred for suspected immune dysregulation or with a known immune-mediated disease and failing to respond to standard therapy
Exclusion Criteria1
- Healthy control individuals will be excluded on the basis of having a diagnosis of an immune mediated disorder, immunomodulatory treatment or current infection or cancer.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Variable protocols for combined immunomodulatory therapies currently in use for different forms of immune dysregulation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06248957